South Wales, June 20 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "EXKALBRI" on June 4. The details about the trademark application no. UK00004213861 published in the journal no. 2025/025 (June 20).

With Dennemeyer & Company Limited as representative, AstraZeneca AB filed the trademark application for the below mentioned good(s)/service(s).

Class 5 : Pharmaceutical preparations and substances for the treatment of cardiovascular, metabolic, and renal diseases and disorders.

The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004213861

Disclaimer: Curated by HT Syndication.